Cytosorbents Historical Balance Sheet

CTSO Stock

USD 1.04 0.01 0.97%

Trend analysis of Cytosorbents Crp balance sheet accounts such as Short Long Term Debt Total of 22.1 M, Total Current Liabilities of 17.6 M or Net Debt of 4 M provides information on Cytosorbents Crp's total assets, liabilities, and equity, which is the actual value of Cytosorbents Crp to its prevalent stockholders. By breaking down trends over time using Cytosorbents Crp balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cytosorbents Crp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cytosorbents Crp is a good buy for the upcoming year.

Cytosorbents Crp Inventory

4.44 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

About Cytosorbents Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cytosorbents Crp at a specified time, usually calculated after every quarter, six months, or one year. Cytosorbents Crp Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cytosorbents Crp and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cytosorbents currently owns. An asset can also be divided into two categories, current and non-current.

Cytosorbents Crp Balance Sheet Chart

At this time, Cytosorbents Crp's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 25th of March 2025, Total Liabilities is likely to grow to about 36.2 M, though Retained Earnings are likely to grow to (241.5 M).

Total Assets Short Long Term Debt Total Total Current Liabilities Common Stock Total Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Cytosorbents Crp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cytosorbents Crp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cytosorbents Crp balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cytosorbents Crp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Most accounts from Cytosorbents Crp's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cytosorbents Crp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.At this time, Cytosorbents Crp's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 25th of March 2025, Total Liabilities is likely to grow to about 36.2 M, though Retained Earnings are likely to grow to (241.5 M).

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	18.3M	18.3M	21.1M	22.1M
Total Assets	63.2M	53.3M	61.2M	64.3M

Short Long Term Debt Total Total Assets

Cytosorbents Crp balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Net Debt	Retained Earnings	Cash	Common Stock Total Equity	Common Stock Shares Outstanding	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Other Current Liab	Total Stockholder Equity	Property Plant And Equipment Net	Non Current Assets Total	Cash And Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Common Stock	Accounts Payable	Non Currrent Assets Other	Other Current Assets	Good Will	Intangible Assets	Other Assets	Property Plant Equipment
Total Assets		0.6	0.83	-0.6	-0.8	0.85	-0.36	0.86	0.66	0.71	0.9	0.94	0.94	0.73	0.78	0.85	0.43	0.88	-0.35	0.7	0.62	0.8	0.92	0.94	0.87	0.8
Short Long Term Debt Total	0.6		0.88	0.25	-0.85	0.15	-0.41	0.87	0.89	0.87	0.26	0.79	0.34	0.87	0.88	0.14	0.76	0.84	-0.39	0.85	0.32	0.54	0.84	0.82	0.22	0.81
Total Current Liabilities	0.83	0.88		-0.13	-0.91	0.48	-0.38	0.95	0.88	0.87	0.56	0.9	0.63	0.87	0.89	0.47	0.66	0.96	-0.36	0.94	0.44	0.58	0.95	0.93	0.54	0.85
Net Debt	-0.6	0.25	-0.13		0.13	-0.92	0.15	-0.2	0.12	0.11	-0.86	-0.36	-0.8	0.08	0.02	-0.92	0.3	-0.22	0.16	0.04	-0.53	-0.42	-0.28	-0.33	-0.79	-0.11
Retained Earnings	-0.8	-0.85	-0.91	0.13		-0.47	0.32	-0.95	-0.84	-0.82	-0.58	-0.88	-0.61	-0.82	-0.85	-0.47	-0.66	-0.95	0.29	-0.79	-0.48	-0.72	-0.91	-0.9	-0.5	-0.78
Cash	0.85	0.15	0.48	-0.92	-0.47		-0.29	0.54	0.25	0.23	0.99	0.68	0.94	0.26	0.33	1.0	0.03	0.55	-0.29	0.3	0.69	0.66	0.62	0.67	0.9	0.43
Common Stock Total Equity	-0.36	-0.41	-0.38	0.15	0.32	-0.29		-0.48	-0.07	-0.24	-0.33	-0.45	-0.42	-0.25	-0.28	-0.3	0.18	-0.35	1.0	-0.33	-0.36	-0.27	-0.43	-0.43	-0.2	-0.27
Common Stock Shares Outstanding	0.86	0.87	0.95	-0.2	-0.95	0.54	-0.48		0.82	0.83	0.63	0.92	0.69	0.83	0.87	0.54	0.59	0.98	-0.46	0.86	0.51	0.68	0.96	0.95	0.55	0.81
Total Liab	0.66	0.89	0.88	0.12	-0.84	0.25	-0.07	0.82		0.87	0.34	0.77	0.36	0.87	0.88	0.24	0.93	0.84	-0.04	0.86	0.33	0.57	0.83	0.82	0.35	0.82
Property Plant And Equipment Gross	0.71	0.87	0.87	0.11	-0.82	0.23	-0.24	0.83	0.87		0.33	0.8	0.48	1.0	0.99	0.23	0.73	0.87	-0.21	0.89	0.18	0.57	0.83	0.81	0.42	0.9
Total Current Assets	0.9	0.26	0.56	-0.86	-0.58	0.99	-0.33	0.63	0.34	0.33		0.76	0.96	0.36	0.43	0.99	0.12	0.63	-0.33	0.38	0.71	0.74	0.7	0.75	0.91	0.52
Other Current Liab	0.94	0.79	0.9	-0.36	-0.88	0.68	-0.45	0.92	0.77	0.8	0.76		0.81	0.82	0.86	0.68	0.56	0.92	-0.43	0.77	0.6	0.82	0.96	0.97	0.73	0.88
Total Stockholder Equity	0.94	0.34	0.63	-0.8	-0.61	0.94	-0.42	0.69	0.36	0.48	0.96	0.81		0.5	0.56	0.94	0.1	0.71	-0.42	0.47	0.62	0.73	0.76	0.79	0.91	0.62
Property Plant And Equipment Net	0.73	0.87	0.87	0.08	-0.82	0.26	-0.25	0.83	0.87	1.0	0.36	0.82	0.5		1.0	0.26	0.74	0.87	-0.22	0.86	0.19	0.62	0.84	0.82	0.45	0.92
Non Current Assets Total	0.78	0.88	0.89	0.02	-0.85	0.33	-0.28	0.87	0.88	0.99	0.43	0.86	0.56	1.0		0.32	0.73	0.9	-0.25	0.88	0.26	0.66	0.88	0.87	0.5	0.93
Cash And Short Term Investments	0.85	0.14	0.47	-0.92	-0.47	1.0	-0.3	0.54	0.24	0.23	0.99	0.68	0.94	0.26	0.32		0.02	0.55	-0.3	0.29	0.68	0.66	0.62	0.67	0.9	0.43
Non Current Liabilities Total	0.43	0.76	0.66	0.3	-0.66	0.03	0.18	0.59	0.93	0.73	0.12	0.56	0.1	0.74	0.73	0.02		0.62	0.2	0.66	0.18	0.48	0.62	0.6	0.15	0.68
Other Stockholder Equity	0.88	0.84	0.96	-0.22	-0.95	0.55	-0.35	0.98	0.84	0.87	0.63	0.92	0.71	0.87	0.9	0.55	0.62		-0.33	0.87	0.49	0.69	0.96	0.94	0.58	0.83
Common Stock	-0.35	-0.39	-0.36	0.16	0.29	-0.29	1.0	-0.46	-0.04	-0.21	-0.33	-0.43	-0.42	-0.22	-0.25	-0.3	0.2	-0.33		-0.3	-0.36	-0.26	-0.41	-0.42	-0.2	-0.25
Accounts Payable	0.7	0.85	0.94	0.04	-0.79	0.3	-0.33	0.86	0.86	0.89	0.38	0.77	0.47	0.86	0.88	0.29	0.66	0.87	-0.3		0.36	0.38	0.87	0.83	0.4	0.81
Non Currrent Assets Other	0.62	0.32	0.44	-0.53	-0.48	0.69	-0.36	0.51	0.33	0.18	0.71	0.6	0.62	0.19	0.26	0.68	0.18	0.49	-0.36	0.36		0.58	0.63	0.64	0.46	0.27
Other Current Assets	0.8	0.54	0.58	-0.42	-0.72	0.66	-0.27	0.68	0.57	0.57	0.74	0.82	0.73	0.62	0.66	0.66	0.48	0.69	-0.26	0.38	0.58		0.75	0.79	0.65	0.63
Good Will	0.92	0.84	0.95	-0.28	-0.91	0.62	-0.43	0.96	0.83	0.83	0.7	0.96	0.76	0.84	0.88	0.62	0.62	0.96	-0.41	0.87	0.63	0.75		0.99	0.62	0.83
Intangible Assets	0.94	0.82	0.93	-0.33	-0.9	0.67	-0.43	0.95	0.82	0.81	0.75	0.97	0.79	0.82	0.87	0.67	0.6	0.94	-0.42	0.83	0.64	0.79	0.99		0.68	0.84
Other Assets	0.87	0.22	0.54	-0.79	-0.5	0.9	-0.2	0.55	0.35	0.42	0.91	0.73	0.91	0.45	0.5	0.9	0.15	0.58	-0.2	0.4	0.46	0.65	0.62	0.68		0.65
Property Plant Equipment	0.8	0.81	0.85	-0.11	-0.78	0.43	-0.27	0.81	0.82	0.9	0.52	0.88	0.62	0.92	0.93	0.43	0.68	0.83	-0.25	0.81	0.27	0.63	0.83	0.84	0.65

Click cells to compare fundamentals

Cytosorbents Crp Account Relationship Matchups

Cytosorbents Crp balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	90.0M	89.5M	63.2M	53.3M	61.2M	64.3M
Short Long Term Debt Total	1.0M	13.8M	18.3M	18.3M	21.1M	22.1M
Total Current Liabilities	10.2M	13.7M	9.7M	14.5M	16.7M	17.6M
Net Debt	(70.4M)	(38.3M)	(3.9M)	4.2M	3.8M	4.0M
Retained Earnings	(196.6M)	(221.2M)	(254.0M)	(282.5M)	(254.3M)	(241.5M)
Cash	71.4M	52.1M	22.1M	14.1M	16.3M	13.2M
Common Stock Total Equity	32.6K	43.2K	43.5K	43.6K	39.3K	51.6K
Common Stock Shares Outstanding	38.8M	43.4M	43.6M	44.7M	51.4M	53.9M
Liabilities And Stockholders Equity	90.0M	89.5M	63.2M	53.3M	61.2M	64.3M
Total Liab	10.7M	26.9M	27.9M	30.0M	34.5M	36.2M
Property Plant And Equipment Gross	3.1M	18.6M	23.3M	25.2M	28.9M	30.4M
Total Current Assets	82.5M	64.3M	33.8M	25.7M	29.6M	17.6M
Accumulated Other Comprehensive Income	(1.7M)	525.6K	2.3M	529.3K	608.7K	639.2K
Other Current Liab	7.0M	9.5M	7.9M	6.4M	7.4M	7.8M
Total Stockholder Equity	79.2M	62.6M	35.4M	23.3M	26.8M	28.1M
Property Plant And Equipment Net	3.1M	18.6M	23.3M	22.1M	25.4M	26.7M
Non Current Assets Total	7.5M	25.2M	29.5M	27.6M	31.7M	33.3M
Cash And Short Term Investments	71.4M	52.1M	22.1M	14.1M	16.3M	14.1M
Non Current Liabilities Total	582K	13.3M	18.1M	15.4M	17.8M	18.6M
Other Stockholder Equity	277.5M	283.2M	287.0M	305.2M	351.0M	368.5M
Common Stock	43.2K	43.5K	43.6K	54.2K	48.8K	53.5K
Accounts Payable	1.8M	2.8M	1.7M	3.8M	4.4M	4.6M
Non Currrent Assets Other	4.3M	1.9M	1.7M	1.5M	1.8M	1.2M
Other Current Assets	3.2M	2.9M	5.0M	1.8M	2.1M	1.2M
Intangible Assets	4.2M	4.7M	4.4M	3.9M	4.5M	4.7M
Other Assets	123.5K	5.4M	6.6M	1.7M	2.0M	1.1M
Property Plant Equipment	3.0M	2.1M	18.6M	10.7M	12.4M	13.0M
Long Term Debt	9.3M	13.4M	5M	2.5M	2.9M	3.8M
Net Receivables	5.2M	4.5M	5.7M	6.1M	7.0M	7.3M
Retained Earnings Total Equity	(188.8M)	(196.6M)	(221.2M)	(254.0M)	(228.6M)	(217.2M)
Inventory	2.7M	4.8M	3.5M	3.7M	4.2M	4.4M
Short Term Debt	447.5K	570.6K	108.9K	2.9M	3.3M	3.5M
Net Tangible Assets	56.6K	79.2M	62.6M	35.4M	40.7M	23.3M
Current Deferred Revenue	1.0M	2.2M	1.7M	1.4M	1.6M	968.5K
Capital Surpluse	191.6M	277.5M	283.2M	287.0M	330.1M	215.6M

When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:

How To Invest In Cytosorbents

Details

Is Cytosorbents Stock a good investment?

Details

What is Cytosorbents Crp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.36)

Revenue Per Share

0.72

Quarterly Revenue Growth

0.066

Return On Assets

(0.28)

Return On Equity

(1.19)

The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cytosorbents Historical Balance Sheet

Cytosorbents Crp Inventory

4.44 Million

About Cytosorbents Balance Sheet Analysis

Cytosorbents Crp Balance Sheet Chart

Total Assets

Total Current Liabilities

Common Stock Total Equity

Cytosorbents Crp balance sheet Correlations

Cytosorbents Crp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cytosorbents Crp balance sheet Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Property Plant And Equipment Net	+ 1.0	Property Plant And Equipment Gross
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash
Non Current Assets Total	+ 0.99	Property Plant And Equipment Gross

Other Stockholder Equity	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Cash And Short Term Investments	- 0.92	Net Debt
Cash	- 0.92	Net Debt
Good Will	- 0.91	Retained Earnings
Retained Earnings	- 0.91	Total Current Liabilities